BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 32295080)

  • 1. Adenoviral Vectors Meet Gene Editing: A Rising Partnership for the Genomic Engineering of Human Stem Cells and Their Progeny.
    Tasca F; Wang Q; Gonçalves MAFV
    Cells; 2020 Apr; 9(4):. PubMed ID: 32295080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Viruses as Genome Editing Devices.
    Chen X; Gonçalves MA
    Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadening the reach and investigating the potential of prime editors through fully viral gene-deleted adenoviral vector delivery.
    Wang Q; Liu J; Janssen JM; Tasca F; Mei H; Gonçalves MAFV
    Nucleic Acids Res; 2021 Nov; 49(20):11986-12001. PubMed ID: 34669958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus vectors in hematopoietic stem cell genome editing.
    Li C; Lieber A
    FEBS Lett; 2019 Dec; 593(24):3623-3648. PubMed ID: 31705806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
    Termglinchan V; Seeger T; Chen C; Wu JC; Karakikes I
    Methods Mol Biol; 2017; 1521():55-68. PubMed ID: 27910041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of viral vectors as vehicles for DMD gene editing.
    Maggio I; Chen X; Gonçalves MA
    Genome Med; 2016 May; 8(1):59. PubMed ID: 27215286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.
    Hotta A; Yamanaka S
    Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites.
    Leitão AL; Costa MC; Enguita FJ
    J Biotechnol; 2017 Jan; 241():50-60. PubMed ID: 27845165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of
    Brescia M; Janssen JM; Liu J; Gonçalves MAFV
    Cells; 2020 Apr; 9(4):. PubMed ID: 32252479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
    Yu KR; Natanson H; Dunbar CE
    Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV Vectorization of DSB-mediated Gene Editing Technologies.
    Moser RJ; Hirsch ML
    Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
    Chaterji S; Ahn EH; Kim DH
    Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System.
    Porteus MH; Pavel-Dinu M; Pai SY
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):647-665. PubMed ID: 35773054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing in Stem Cells for Disease Therapeutics.
    Song M; Ramakrishna S
    Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Engineering for Stem Cell Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing technologies to fight infectious diseases.
    Trevisan M; Palù G; Barzon L
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas Genome Editing in
    Mesaki K; Yamamoto H; Juvet S; Yeung J; Guan Z; Akhter A; Yao Y; Dickie C; Mangat H; Wang A; Wilson GW; Mariscal A; Hu J; Davidson AR; Kleinstiver BP; Cypel M; Liu M; Keshavjee S
    Hum Gene Ther; 2024 Jun; 35(11-12):374-387. PubMed ID: 38717950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key to Delivery: The (Epi-)genome Editing Vector Toolbox.
    Just S; Büning H
    Methods Mol Biol; 2018; 1767():147-166. PubMed ID: 29524133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and Prospects of Gene Editing in Pluripotent Stem Cells.
    Zhang Z; Bao X; Lin CP
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.